On Monday, Merck & Co Inc (NYSE: MRK) opened higher 0.72% from the last session, before settling in for the closing price of $79.29. Price fluctuations for MRK have ranged from $73.31 to $120.30 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 12.04% over the last five years. Company’s average yearly earnings per share was noted 16.61% at the time writing. With a float of $2.51 billion, this company’s outstanding shares have now reached $2.51 billion.
The firm has a total of 75000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 76.42%, operating margin of 31.91%, and the pretax margin is 31.55%.
Merck & Co Inc (MRK) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Merck & Co Inc is 0.06%, while institutional ownership is 80.17%. The most recent insider transaction that took place on Apr 25 ’25, was worth 352,723. In this transaction SVP Fin. – Global Controller of this company sold 4,262 shares at a rate of $82.76, taking the stock ownership to the 7,778 shares. Before that another transaction happened on Apr 25 ’25, when Company’s Officer proposed sale 4,262 for $82.76, making the entire transaction worth $352,723.
Merck & Co Inc (MRK) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 16.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.27% during the next five years compared to 12.04% growth over the previous five years of trading.
Merck & Co Inc (NYSE: MRK) Trading Performance Indicators
Check out the current performance indicators for Merck & Co Inc (MRK). In the past quarter, the stock posted a quick ratio of 1.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.16. Likewise, its price to free cash flow for the trailing twelve months is 11.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.49, a number that is poised to hit 2.37 in the next quarter and is forecasted to reach 9.66 in one year’s time.
Technical Analysis of Merck & Co Inc (MRK)
Analysing the last 5-days average volume posted by the [Merck & Co Inc, MRK], we can find that recorded value of 17.2 million was better than the volume posted last year of 15.87 million. As of the previous 9 days, the stock’s Stochastic %D was 28.39%.
During the past 100 days, Merck & Co Inc’s (MRK) raw stochastic average was set at 28.44%, which indicates a significant decrease from 37.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.06 in the past 14 days, which was lower than the 2.22 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $80.34, while its 200-day Moving Average is $89.96.
